Evidence map›Paper›PMID 27913725›Full record

ArticleNucleic acids research2017

In vivo expression technology and 5' end mapping of the Borrelia burgdorferi transcriptome identify novel RNAs expressed during mammalian infection.

Philip P Adams, Carlos Flores Avile, Niko Popitsch, Ivana Bilusic, Renée Schroeder, Meghan Lybecker, Mollie W Jewett

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. TheInfection and immunity · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Infection and immunity · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Hitchhiker's Guide toJournal of bacteriology · 2024
    Review
  12. Article
  13. Extracellular vesicle formation inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. bioRxiv : the preprint server for biology · 2024
    Article
  16. Broadly conserved FlgV controls flagellar assembly andbioRxiv : the preprint server for biology · 2024
    Article
  17. σeLife · 2023
    Article
  18. Article
  19. Article
  20. Chemotaxis Coupling Protein CheWInfection and immunity · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Philip P AdamsDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL 32827, USA.
Carlos Flores AvileDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL 32827, USA.
Niko PopitschWellcome Trust Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Ivana BilusicDepartment of Biochemistry and Cell Biology, Max F. Perutz Laboratories, University of Vienna, Vienna 1030, Austria.
Renée SchroederDepartment of Biochemistry and Cell Biology, Max F. Perutz Laboratories, University of Vienna, Vienna 1030, Austria.
Meghan LybeckerDepartment of Biology, University of Colorado Colorado Springs, Colorado Springs, CO 80918, USA.
Mollie W JewettDivision of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL 32827, USA Mollie.Jewett@ucf.edu.ORCID 0000-0003-3130-3795
University of Central Florida · USUniversity of Vienna · ATCentre for Human Genetics · GBUniversity of Colorado Colorado Springs · US

Funding

Determination of the genetic basis for B. burgdorferi mammalian infectivityR01AI099094 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI Mollie W Jewett · 2013 to 2026
$4.0M
NIAID NIH HHS R01 AI099094
6 · The paper itself

Abstract

Borrelia burgdorferi, the bacterial pathogen responsible for Lyme disease, modulates its gene expression profile in response to the environments encountered throughout its tick-mammal infectious cycle. To begin to characterize the B. burgdorferi transcriptome during murine infection, we previously employed an in vivo expression technology-based approach (BbIVET). This identified 233 putative promoters, many of which mapped to un-annotated regions of the complex, segmented genome. Herein, we globally identify the 5' end transcriptome of B. burgdorferi grown in culture as a means to validate non-ORF associated promoters discovered through BbIVET. We demonstrate that 119 BbIVET promoters are associated with transcription start sites (TSSs) and validate novel RNA transcripts using Northern blots and luciferase promoter fusions. Strikingly, 49% of BbIVET promoters were not found to associate with TSSs. This finding suggests that these sequences may be primarily active in the mammalian host. Furthermore, characterization of the 6042 B. burgdorferi TSSs reveals a variety of RNAs including numerous antisense and intragenic transcripts, leaderless RNAs, long untranslated regions and a unique nucleotide frequency for initiating intragenic transcription. Collectively, this is the first comprehensive map of TSSs in B. burgdorferi and characterization of previously un-annotated RNA transcripts expressed by the spirochete during murine infection.

Indexed as

Gene Expression ProfilingGene Expression Regulation, BacterialTranscriptomeAnimalsBorrelia burgdorferiGene ExpressionGenes, ReporterGenome, BacterialGenomicsHigh-Throughput Nucleotide SequencingHumansLyme DiseaseMicePromoter Regions, GeneticReproducibility of ResultsTranscription Initiation SiteUntranslated Regions

Identifiers

PMID27913725
PMCPMC5314773
OpenAlexW2560560741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.